With an extensive background in technology and healthcare investments, the fund manager has successfully navigated various stages of the investment lifecycle. They have completed over 30 deals across Europe and North America, emphasizing operator-first strategies that prioritize founder-driven insights. Their portfolio boasts notable exits in emerging sectors such as fintech and biopharma, reflecting a data-driven approach to identifying high-growth opportunities. Their strategic style combines rigorous market analysis with a commitment to thematic investing, ensuring alignment with future industry trends.